ArticleJournal of thoracic disease2018

A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancer.

Konstantin H Dragnev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.